2008
DOI: 10.1007/s00268-007-9453-0
|View full text |Cite
|
Sign up to set email alerts
|

Papillary Microcarcinoma

Abstract: Background Papillary microcarcinoma (PMC) is increasing in incidence because of diagnosis by ultrasound-guided fine-needle aspiration cytology. Methods Between January 1966 and December 1995, we treated 6019 patients with papillary cancer; among them, 2070 patients with PMC were studied. Results PMC is essentially very similar to papillary cancer that is 11 mm or larger and has a very good prognosis. Smaller tumors and younger patients have a better prognosis. Among PMC, larger tumors (6-10 mm) recur in 14% at… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

6
170
0
5

Year Published

2010
2010
2019
2019

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 204 publications
(181 citation statements)
references
References 29 publications
6
170
0
5
Order By: Relevance
“…Importantly, the ATA Guidelines recognise that nodules < 1 cm rarely harbour clinically significant cancer and do not routinely require evaluation because of the low cost benefit ratio. However some small nodules, especially those > 0.5 cm, may be considered for FNAB if they are associated with abnormal lymph nodes on palpation or imaging at presentation, ‘high risk’ history, focal avidity on PET scanning or suspicious ultrasound features 2 , 18 . Guidelines from the American Association of Clinical Endocrinologists and Society of Radiologists in Ultrasound similarly use suspicious ultrasound findings to recommend FNAB although their size criteria differ from the ATA Guidelines 1 , 2 , 13 .…”
Section: Guidelines For Recommending Fine‐needle Aspiration Biopsymentioning
confidence: 99%
“…Importantly, the ATA Guidelines recognise that nodules < 1 cm rarely harbour clinically significant cancer and do not routinely require evaluation because of the low cost benefit ratio. However some small nodules, especially those > 0.5 cm, may be considered for FNAB if they are associated with abnormal lymph nodes on palpation or imaging at presentation, ‘high risk’ history, focal avidity on PET scanning or suspicious ultrasound features 2 , 18 . Guidelines from the American Association of Clinical Endocrinologists and Society of Radiologists in Ultrasound similarly use suspicious ultrasound findings to recommend FNAB although their size criteria differ from the ATA Guidelines 1 , 2 , 13 .…”
Section: Guidelines For Recommending Fine‐needle Aspiration Biopsymentioning
confidence: 99%
“…In addition, the ratio of malignant and benign was higher in younger patients, although age was not an independent predictor of PTMC (10,11,13).…”
Section: Discussionmentioning
confidence: 81%
“…Both benign and malignant tumors demonstrated intermediate signal intensity on T1WI and high signal intensity on T2WI, even if in our case showed high signal intensity in T1WI and STIR. Additional investigations are required to determine malignancy such us US or FNA (7,(9)(10)(11).…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations